Fortescue Ltd

FMG

Fortescue Ltd. engages in the development of iron ore deposits. The company is headquartered in Perth, Western Australia. The firm operates through two segments: Metals, and Energy. The Metals segment is engaged in the exploration, development, production, processing, sale and transportation of iron ore, and the exploration for other minerals. The Energy segment is engaged in the development of green electricity, green hydrogen, and green ammonia projects. Through its growth project Iron Bridge and its interest in the Belinga Iron Ore Project in Gabon, it is investing in the growth of its iron ore business. Its integrated operations in the Pilbara include the Chichester, Solomon and Western mining hubs. Its mining infrastructure is connected to the five berth Herb Elliott Port and Judith Street Harbour towage facility in Port Hedland. The Solomon Hub in the Hamersley Ranges is located 60 kilometers (km) north of Tom Price and 120km to the west of the Chichester Hub.

Imugene Limited

IMU

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

Air New Zealand Limited

AIZ

Air New Zealand Ltd. engages in the transportation of passengers and cargo on an integrated network of scheduled airline services. Its geographical segments include New Zealand, Australia and Pacific Islands, Asia, the United Kingdom and Europe, and America. The firm has approximately 104 operating aircraft ranging from Boeing 787-9 Dreamliners and Airbus A320s to ATRs and Q300s, offering customers. The company has domestic business, connecting customers and cargo to over 20 different regions around New Zealand. Internationally, the airline has direct flights to cities across Australia, Asia, the Pacific Islands, and the United States. Its operating fleet includes Boeing 777-300ER, Boeing 787-9 Dreamliner, AirbusA321neo, AirbusA320neo, AirbusA320ceo, ATR 72-600, and Bombardier Q300. The company is a supplier of aircraft, and component maintenance, repair, and overhaul (MRO) services to customers in New Zealand, Australia, Asia, the Americas, and Europe.

Pilbara Minerals Limited

PLS

Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum (tpa) lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.